Extended-spectrum β-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings

Journal of Medical Microbiology

Volumn 60, Issue 4, 2011, Pages 500-507

  Chandel, Dinesh S ^a,b   Johnson, Judith A ^c   Chaudhry, Rama ^d   Sharma, Nidhi ^e   Shinkre, Nandita ^e   Parida, Sailajanandan ^f   Misra, Pravas R ^b   Panigrahi, Pinaki ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Asian Institute of Public Health   (India)

^c UNIVERSITY OF FLORIDA   (United States)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e BYL NAIR CHARITABLE HOSPITAL   (India)

^f SCB MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM;

ALERTNESS; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD CULTURE; CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; EPIDEMIC; ESCHERICHIA COLI; GENETIC VARIABILITY; GEOGRAPHY; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; HUMAN; INDIA; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RURAL AREA; URBAN AREA;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; GENETIC VARIATION; GENOTYPE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INDIA; INFANT; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; RURAL POPULATION; SEPSIS; URBAN POPULATION;

EID: 79953006966     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.027375-0     Document Type: Article

References (31)

1. Anandan, S., Thomas, N., Veeraraghavan, B. & Jana, A. K. (2009). Prevalence of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella spp in a neonatal intensive care unit. Indian Pediatr 46, 1106-1107.
2. Arpin, C., Dubois, V., Coulange, L., André, C., Fischer, I., Noury, P., Grobost, F., Brochet, J. P., Jullin, J. & other authors (2003). Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47, 3506-3514.
3. Bagattini, M., Crivaro, V., Di Popolo, A., Gentile, F., Scarcella, A., Triassi, M., Villari, P. & Zarrilli, R. (2006). Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 57, 979-982.
4. Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A. & Carmeli, Y. (2006). Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42, 925-934.
5. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
6. Calbo, E., Romaní, V., Xercavins, M., Gómez, L., Vidal, C. G., Quintana, S., Vila, J. & Garau, J. (2006). Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother 57, 780-783.
7. Cartelle, M., del Mar Tomas, M., Pertega, S., Beceiro, A., Dominguez, M. A., Velasco, D., Molina, F., Villanueva, R. & Bou, G. (2004). Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J Clin Microbiol 42, 4242-4249. (Pubitemid 39296151)
8. Decré, D., Gachot, B., Lucet, J. C., Arlet, G., Bergogne-Bérézin, E. & Régnier, B. (1998). Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 27, 834-844.
9. Dubois, V., De Barbeyrac, B., Rogues, A.-M., Arpin, C., Coulange, L., Andre, C., M'zali, F., Megraud, F. & Quentin, C. (2010). CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. J Antimicrob Chemother 65, 1368-1371.
10. Jain, A., Roy, I., Gupta, M. K., Kumar, M. & Agarwal, S. K. (2003). Prevalence of extended-spectrum β-lactamase-producing Gramnegative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 52, 421-425. (Pubitemid 36589169)
11. Jarlier, V., Nicolas, M. H., Fournier, G. & Phillipon, A. (1988). Extended broad-spectrum β-lactamases conferring resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10, 867-878.
12. Kim, Y. K., Pai, H., Lee, H. J., Park, S. E., Choi, E. H., Kim, J., Kim, J.-H. & Kim, E.-C. (2002). Bloodstream infections by extended-spectrum β-lactamase- producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46, 1481-1491. (Pubitemid 34415332)
13. Krishna, B. V. S., Patil, A. B. & Chandrasekhar, M. R. (2007). Extended spectrum β lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. Indian J Pediatr 74, 627-630. (Pubitemid 350029392)
14. Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H. & Fishman, N. O. (2001). Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32, 1162-1171. (Pubitemid 32390110)
15. Manchanda, V., Singh, N. P., Shamweel, A., Eideh, H. K. & Thukral, S. S. (2006). Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae. Indian J Med Microbiol 24, 177-181. (Pubitemid 44315649)
16. Mirelis, B., Navarro, F., Miró, E., Mesa, R. J., Coll, P. & Prats, G. (2003). Community transmission of extended-spectrum β-lactamase. Emerg Infect Dis 9, 1024-1025.
17. National Neonatal-Perinatal Database (1997). Neonatal morbidity and mortality: report of the National Neonatal-Perinatal Database. Indian Pediatr 34, 1039-1042.
18. National Neonatology Forum NNPD Network (2005). Report of the National Neonatal-Perinatal Database (2002-03). Available from http://www.nnfi.org/ images/NNPD-2002-03.pdf
19. NCCLS (2001). Zone diameter interpretive standards. NCCLS global information supplement 21: 40-71.
20. Perilli, M., Dell'Amico, E., Segatore, B., de Massis, M. R., Bianchi, C., Luzzaro, F., Rossolini, G. M., Toniolo, A., Nicoletti, G. & Amicosante, G. (2002). Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J ClinMicrobiol 40, 611-614. (Pubitemid 34130889)
21. Pitout, J. D. & Laupland, K. B. (2008). Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8, 159-166. (Pubitemid 351249250)
22. Rodrigues, C., Shukla, U., Jog, S. & Mehta, A. (2005). Extended-spectrum β-lactamase-producing flora in healthy persons. Emerg Infect Dis 11, 981-982. (Pubitemid 40720873)
23. Rodríguez-Banõ, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R. & Pascual, A. (2004). Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 42, 1089-1094. (Pubitemid 38332830)
24. Sahly, H., Navon-Venezia, S., Roesler, L., Hay, A., Carmeli, Y., Podschun, R., Hennequin, C., Forestier, C. & Ofek, I. (2008). Extended-spectrum β-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 52, 3029-3034.
25. Struelens, M. J. (1996). Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 2, 2-11.
26. Talbot, G. H., Bradley, J., Edwards, J. E., Jr, Gilbert, D., Scheld, M. & Bartlett, J. G. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42, 657-668. (Pubitemid 43271379)
27. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial isolate typing. J Clin Microbiol 33, 2233-2239.
28. Thambu, D., Pichamuthu, K., Varghese, G. M. & Subramanian, S. (2006). Community-acquired, fatal extended spectrum β lactamase producing Klebsiella pneumoniae splenic abscess and sepsis. J Postgrad Med 52, 328-329. (Pubitemid 44862788)
29. The India Antimicrobial Resistance Study Group, Mathai, D., Rhomberg, P. R., Biedenbach, D. J. & Jones, R. N. (2002). Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 44, 367-377.
30. Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F. & Cantón, R. (2004). Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during non-outbreak situations in Spain. J Clin Microbiol 42, 4769-4775. (Pubitemid 39362401)
31. Weber, M. W., Carlin, J. B., Gatchalian, S., Lehmann, D., Muhe, L., Mulholland, E. K. & WHO Young Infants Study Group (2003). Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J 22, 711-717.